Table of Contents

2018-2023 Global Palonosetron Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Palonosetron Consumption 2013-2023
  • 2.1.2 Palonosetron Consumption CAGR by Region
• 2.2 Palonosetron Segment by Type
  • 2.2.1 Injection 0.25 mg/5 mL
  • 2.2.2 Injection 20 mcg/kg (max 1.5 mg)
• 2.3 Palonosetron Consumption by Type
  • 2.3.1 Global Palonosetron Consumption Market Share by Type (2013-2018)
  • 2.3.2 Global Palonosetron Revenue and Market Share by Type (2013-2018)
  • 2.3.3 Global Palonosetron Sale Price by Type (2013-2018)
• 2.4 Palonosetron Segment by Application
  • 2.4.1 Adults
  • 2.4.2 Children
• 2.5 Palonosetron Consumption by Application
  • 2.5.1 Global Palonosetron Consumption Market Share by Application (2013-2018)
  • 2.5.2 Global Palonosetron Value and Market Share by Application (2013-2018)
  • 2.5.3 Global Palonosetron Sale Price by Application (2013-2018)

3 Global Palonosetron by Players

• 3.1 Global Palonosetron Sales Market Share by Players
  • 3.1.1 Global Palonosetron Sales by Players (2016-2018)
  • 3.1.2 Global Palonosetron Sales Market Share by Players (2016-2018)
• 3.2 Global Palonosetron Revenue Market Share by Players
  • 3.2.1 Global Palonosetron Revenue by Players (2016-2018)
  • 3.2.2 Global Palonosetron Revenue Market Share by Players (2016-2018)
• 3.3 Global Palonosetron Sale Price by Players
• 3.4 Global Palonosetron Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Palonosetron Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Palonosetron Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Palonosetron by Regions

• 4.1 Palonosetron by Regions
  • 4.1.1 Global Palonosetron Consumption by Regions
  • 4.1.2 Global Palonosetron Value by Regions
• 4.2 Americas Palonosetron Consumption Growth
• 4.3 APAC Palonosetron Consumption Growth
• 4.4 Europe Palonosetron Consumption Growth
• 4.5 Middle East & Africa Palonosetron Consumption Growth

5 Americas

• 5.1 Americas Palonosetron Consumption by Countries
  • 5.1.1 Americas Palonosetron Consumption by Countries (2013-2018)
  • 5.1.2 Americas Palonosetron Value by Countries (2013-2018)
• 5.2 Americas Palonosetron Consumption by Type
• 5.3 Americas Palonosetron Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Palonosetron Consumption by Countries
  • 6.1.1 APAC Palonosetron Consumption by Countries (2013-2018)
  • 6.1.2 APAC Palonosetron Value by Countries (2013-2018)
• 6.2 APAC Palonosetron Consumption by Type
• 6.3 APAC Palonosetron Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Palonosetron by Countries
  • 7.1.1 Europe Palonosetron Consumption by Countries (2013-2018)
  • 7.1.2 Europe Palonosetron Value by Countries (2013-2018)
• 7.2 Europe Palonosetron Consumption by Type
• 7.3 Europe Palonosetron Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Palonosetron by Countries
  • 8.1.1 Middle East & Africa Palonosetron Consumption by Countries (2013-2018)
  • 8.1.2 Middle East & Africa Palonosetron Value by Countries (2013-2018)
• 8.2 Middle East & Africa Palonosetron Consumption by Type
• 8.3 Middle East & Africa Palonosetron Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Palonosetron Distributors
• 10.3 Palonosetron Customer

11 Global Palonosetron Market Forecast

• 11.1 Global Palonosetron Consumption Forecast (2018-2023)
• 11.2 Global Palonosetron Forecast by Regions
  • 11.2.1 Global Palonosetron Forecast by Regions (2018-2023)
  • 11.2.2 Global Palonosetron Value Forecast by Regions (2018-2023)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Palonosetron Forecast by Type
• 11.8 Global Palonosetron Forecast by Application

12 Key Players Analysis

• 12.1 Helsinn Therapeutics
  • 12.1.1 Company Details
  • 12.1.2 Palonosetron Product Offered
  • 12.1.3 Helsinn Therapeutics Palonosetron Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.1.4 Main Business Overview
  • 12.1.5 Helsinn Therapeutics News
• 12.2 Teva
  • 12.2.1 Company Details
  • 12.2.2 Palonosetron Product Offered
  • 12.2.3 Teva Palonosetron Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.2.4 Main Business Overview
  • 12.2.5 Teva News
• 12.3 Dr. Reddys Laboratories
  • 12.3.1 Company Details
  • 12.3.2 Palonosetron Product Offered
  • 12.3.3 Dr. Reddys Laboratories Palonosetron Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.3.4 Main Business Overview
  • 12.3.5 Dr. Reddys Laboratories News
• 12.4 Cipla
  • 12.4.1 Company Details
  • 12.4.2 Palonosetron Product Offered
  • 12.4.3 Cipla Palonosetron Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.4.4 Main Business Overview
  • 12.4.5 Cipla News
• 12.5 Pfizer
  • 12.5.1 Company Details
  • 12.5.2 Palonosetron Product Offered
  • 12.5.3 Pfizer Palonosetron Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.5.4 Main Business Overview
  • 12.5.5 Pfizer News
• 12.6 Sandoz
  • 12.6.1 Company Details
  • 12.6.2 Palonosetron Product Offered
  • 12.6.3 Sandoz Palonosetron Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.6.4 Main Business Overview
  • 12.6.5 Sandoz News
• 12.7 Aurobindo
  • 12.7.1 Company Details
  • 12.7.2 Palonosetron Product Offered
  • 12.7.3 Aurobindo Palonosetron Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.7.4 Main Business Overview
  • 12.7.5 Aurobindo News
• 12.8 Sagent Pharmaceuticals
  • 12.8.1 Company Details
  • 12.8.2 Palonosetron Product Offered
  • 12.8.3 Sagent Pharmaceuticals Palonosetron Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.8.4 Main Business Overview
  • 12.8.5 Sagent Pharmaceuticals News
• 12.9 Fresenius Kabi
  • 12.9.1 Company Details
  • 12.9.2 Palonosetron Product Offered
  • 12.9.3 Fresenius Kabi Palonosetron Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.9.4 Main Business Overview
  • 12.9.5 Fresenius Kabi News
• 12.10 Qilu Pharmaceutical
  • 12.10.1 Company Details
  • 12.10.2 Palonosetron Product Offered
  • 12.10.3 Qilu Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.10.4 Main Business Overview
  • 12.10.5 Qilu Pharmaceutical News
• 12.11 Jiangsu Aosaikang Pharmaceutical
• 12.12 Sichuan Hairong Pharmaceutical
• 12.13 Exela Pharma

13 Research Findings and Conclusion

Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).

According to this study, over the next five years the Palonosetron market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Palonosetron business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Palonosetron market by product type, application, key manufacturers and key regions and countries.

This study considers the Palonosetron value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Injection 0.25 mg/5 mL
Injection 20 mcg/kg (max 1.5 mg)
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Adults
Children

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Helsinn Therapeutics
Teva
Dr. Reddys Laboratories
Cipla
Pfizer
Sandoz
Aurobindo
Sagent Pharmaceuticals
Fresenius Kabi
Qilu Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Sichuan Hairong Pharmaceutical
Exela Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Palonosetron consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Palonosetron market by identifying its various subsegments.
Focuses on the key global Palonosetron manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Palonosetron with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Palonosetron submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.